Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis.

Nishida M, Moriyama T, Ishii K, Takashima S, Yoshizaki K, Sugita Y, Yamauchi-Takihara K.

Clin Chim Acta. 2007 Sep;384(1-2):99-104. Epub 2007 Jun 16.

PMID:
17618612
2.

Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome.

Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K.

Circ J. 2007 Aug;71(8):1234-8.

3.

Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men.

Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Takefuji S, Sugiura K, Kondo T, Murohara T, Toyoshima H.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):871-6. Epub 2006 Feb 2.

4.

Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.

Sung SH, Chuang SY, Sheu WH, Lee WJ, Chou P, Chen CH.

Am J Cardiol. 2009 May 15;103(10):1411-6. doi: 10.1016/j.amjcard.2009.01.355. Epub 2009 Apr 1.

PMID:
19427438
5.

Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.

Sabio JM, Vargas-Hitos J, Zamora-Pasadas M, Mediavilla JD, Navarrete N, Ramirez A, Hidalgo-Tenorio C, Jáimez L, Martín J, Jiménez-Alonso J; Grupo Lupus Virgen de las Nieves.

J Rheumatol. 2009 Oct;36(10):2204-11. doi: 10.3899/jrheum.081253. Epub 2009 Sep 1.

PMID:
19723903
6.

Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness.

Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A.

J Atheroscler Thromb. 2007 Apr;14(2):78-85.

7.

High-sensitivity C-reactive protein is independently associated with arterial stiffness in women with metabolic syndrome.

Oh EG, Kim SH, Bang SY, Hyun SS, Im JA, Lee JE, Yoo JY.

J Cardiovasc Nurs. 2012 Jan-Feb;27(1):61-7. doi: 10.1097/JCN.0b013e31820e5a91.

PMID:
21372728
8.

Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study.

Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M.

Diabet Med. 2008 Jun;25(6):747-50. doi: 10.1111/j.1464-5491.2008.02440.x. Epub 2008 Apr 23.

PMID:
18435780
9.

The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.

Nam JS, Park JS, Cho MH, Jee SH, Lee HS, Ahn CW, Lowe WL Jr, Kim KR.

Diabetes Res Clin Pract. 2009 May;84(2):145-51. doi: 10.1016/j.diabres.2009.02.002. Epub 2009 Mar 3.

PMID:
19261346
10.

Further inflammatory information on metabolic syndrome by adiponectin evaluation.

Matsushita K, Tamakoshi K, Yatsuya H, Wada K, Otsuka R, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H.

Int J Cardiol. 2008 Mar 14;124(3):339-44. Epub 2007 Apr 11.

PMID:
17433469
11.

Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men.

Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K.

Cardiovasc Diabetol. 2007 Oct 1;6:27.

12.

Impact of waist circumference versus adiponectin level on subclinical atherosclerosis: a cross-sectional analysis in a sample from the general population.

Holewijn S, den Heijer M, van Tits LJ, Swinkels DW, Stalenhoef AF, de Graaf J.

J Intern Med. 2010 Jun;267(6):588-98. doi: 10.1111/j.1365-2796.2009.02192.x. Epub 2009 Nov 4.

13.

The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.

Ryu SY, Kim KS, Park J, Kang MG, Han MA.

J Prev Med Public Health. 2008 Nov;41(6):413-8. doi: 10.3961/jpmph.2008.41.6.413.

14.

Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes.

Fukui M, Ose H, Kitagawa Y, Kamiuchi K, Nakayama I, Ohta M, Obayashi H, Yamasaki M, Hasegawa G, Yoshikawa T, Nakamura N.

Diabet Med. 2007 Aug;24(8):864-71. Epub 2007 Jun 25.

PMID:
17593243
15.

Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein.

Ahonen TM, Kautiainen HJ, Keinänen-Kiukaanniemi SM, Kumpusalo EA, Vanhala MJ.

Am J Prev Med. 2008 Dec;35(6):598-601. doi: 10.1016/j.amepre.2008.09.011. Epub 2008 Oct 8.

PMID:
18842390
16.

[C-reactive protein and carotid intima-media thickness in a population of middle-aged Koreans].

Suh M, Lee JY, Ahn SV, Kim HC, Suh I.

J Prev Med Public Health. 2009 Jan;42(1):29-34. doi: 10.3961/jpmph.2009.42.1.29. Korean.

17.

IL-18 is involved in vascular injury in end-stage renal disease patients.

Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.

Nephrol Dial Transplant. 2009 Feb;24(2):589-96. doi: 10.1093/ndt/gfn486. Epub 2008 Sep 4.

PMID:
18775894
18.

Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men.

Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A.

J Atheroscler Thromb. 2007 Feb;14(1):36-43.

19.

Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project.

Ferreira I, Boreham CA, Twisk JW, Gallagher AM, Young IS, Murray LJ, Stehouwer CD.

J Hypertens. 2007 May;25(5):1009-20.

PMID:
17414665
20.

High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes.

Tajiri Y, Mimura K, Umeda F.

Obes Res. 2005 Oct;13(10):1810-6.

Supplemental Content

Support Center